Innovate (Innovate) ROCE % : 6.78% (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Innovate ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Innovate's annualized ROCE % for the quarter that ended in Dec. 2023 was 6.78%.

Innovate ROCE % Historical Data

The historical data trend for Innovate's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovate ROCE % Chart

Innovate Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

0.55

0.78

-3.02

1.58

4.95

Innovate Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															3.20	4.84	4.11	7.69	6.78

Innovate ROCE % Calculation

Innovate's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	33.8	/	( ( (1151.7 - 417.2)	+	(1043.6 - 413.8) )	/ 2 )
	=	33.8	/	( (734.5	+	629.8)	/ 2 )
	=	33.8	/	682.15
	=	4.95 %

Innovate's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	39.6	/	( ( (1096.1 - 557.7)	+	(1043.6 - 413.8) )	/ 2 )
	=	39.6	/	( ( 538.4	+	629.8 )	/ 2 )
	=	39.6	/	584.1
	=	6.78 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Innovate (NYSE:VATE) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Innovate ROCE % Related Terms

Thank you for viewing the detailed overview of Innovate's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Innovate (Innovate) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Construction » Innovate Corp (NYSE:VATE) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

PSTA:Germany

Address

295 Madison Avenue, 12th Floor, New York, NY, USA, 10017

Website

https://www.innovatecorp.com

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting stations across the United States.

Executives

Wayne Jr Barr	director	ANACOMP INC, 15378 AVENUE OF SCIENCE, SAN DIEGO CA 92128
Michael J. Sena	officer: Chief Financial Officer	450 PARK AVENUE, 30TH FLOOR, NEW YORK NY 10022
Brian Steven Goldstein	director	295 MADISON AVENUE, 12TH FLOOR, NEW YORK NY 10017
Amy Marie Wilkinson	director	295 MADISON AVENUE, 12TH FLOOR, NEW YORK NY 10017
Shelly Lombard	director	44 MORSE AVENUE, BLOOMFIELD NJ 07003
Avram A Glazer	director	C/O WOODS OVIATT GILMAN LLP, 700 CROSSROADS BUILDING, ROCHESTER NY 14614
Suzi R Herbst	officer: Chief Administrative Officer	C/O HC2 HOLDINGS, INC., 450 PARK AVENUE, 30TH FLOOR, NEW YORK NY 10022
Joseph Anthony Ferraro	officer: Chief Legal Officer & Corp Sec	56 EMILY ROAD, FAR HILLS FL 07931
Continental Ltc, Inc.	10 percent owner	11001 LAKELINE BLVD., STE. 120, AUSTIN TX 78717
Michael Gorzynski	director, 10 percent owner	595 MADISON AVE, FLOOR 29, NEW YORK NY 10022
Continental General Insurance Co	10 percent owner	11001 LAKELINE BLVD., STE. 120, AUSTIN TX 78717
Continental Insurance Group, Ltd.	10 percent owner	11001 LAKELINE BLVD., STE. 120, AUSTIN TX 78717
Percy Rockdale Llc	10 percent owner	595 MADISON AVENUE, 29TH FLOOR, NEW YORK NY 10022
Mg Capital Management Ltd.	10 percent owner	C/O CAMPBELLS LLP, FLOOR 4, WILLOW HOUSE, CRICKET SQUARE, GRAND CAYMAN E9 KY1-9010
Rio Royal Llc	10 percent owner	595 MADISON AVENUE, 29TH FLOOR, NEW YORK NY 10022